Assembly Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $268.0M
Liabilities Breakdown FY2018
Total Liabilities: $57.4M
Asset Breakdown
Total Assets: $268.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $41.5M | 15.5% |
| Accounts Receivable | $2.4M | 0.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $557.0K | 0.2% |
| Goodwill | $12.6M | 4.7% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $210.9M | 78.7% |
Liabilities Breakdown
Total Liabilities: $57.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.7M | 6.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $53.7M | 93.6% |